Literature DB >> 18305374

Complex mechanism underlying transcriptional control of the haplotyped flavin-containing monooxygenase 3 (FMO3) gene in Japanese: different regulation between mutations in 5'-upstream distal region and common element in proximal region.

Makiko Shimizu1, Norie Murayama, Satomi Nagashima, Masaki Fujieda, Hiroshi Yamazaki.   

Abstract

We reported the human flavin-containing monooxygenase 3 (FMO3) haplotypes (Pharmacogenet. Genomics: 17, 827, 2007). The objective was to gain the insight into transcriptional regulation in a Japanese population. The wild-type FMO3 reporter plasmids carrying 5'-flanking sequence from the transcriptional initiation site of the FMO3 haplotype 1 (prepared from three individuals) showed higher luciferase activities in HepG2 cells than those from the FMO3 haplotypes 2 and 3, with the wild-type coding region. Several deletion mutants of the FMO3 haplotype 1 (extending from -5,167 to -1,764, numbered relative to the A of the ATG translational initiation codon) revealed that the region of -2,064 to -1,804 contained an important cis-acting element(s) for activation of the FMO3 gene expression. Putative hepatocyte nuclear factor-4 (HNF-4) binding site and CCAAT box, but not Yin Yang 1 element, could be responsible cis-acting elements of the FMO3 gene, by site-directed mutagenesis analysis. The unknown suppressive cis-element(s) at the 5'-upstream region from -2,064 might show genetic polymorphism, because the FMO3 haplotypes 2 and 3 had three and ten mutations, respectively. These results suggest that the putative HNF-4 binding site and CCAAT box could be responsible cis-acting elements of the FMO3 gene in Japanese.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18305374     DOI: 10.2133/dmpk.23.54

Source DB:  PubMed          Journal:  Drug Metab Pharmacokinet        ISSN: 1347-4367            Impact factor:   3.614


  5 in total

1.  Relationships between flavin-containing mono-oxygenase 3 (FMO3) genotype and trimethylaminuria phenotype in a Japanese population.

Authors:  Makiko Shimizu; Charles K Allerston; Elizabeth A Shephard; Hiroshi Yamazaki; Ian R Phillips
Journal:  Br J Clin Pharmacol       Date:  2014-05       Impact factor: 4.335

2.  Developmental variations in metabolic capacity of flavin-containing mono-oxygenase 3 in childhood.

Authors:  Makiko Shimizu; Travis Denton; Marie Kozono; John R Cashman; J Steven Leeder; Hiroshi Yamazaki
Journal:  Br J Clin Pharmacol       Date:  2011-04       Impact factor: 4.335

3.  Inter-individual variation in flavin-containing monooxygenase 3 in livers from Japanese: correlation with hepatic transcription factors.

Authors:  Satomi Nagashima; Makiko Shimizu; Hiroshi Yano; Norie Murayama; Toshio Kumai; Shinichi Kobayashi; F Peter Guengerich; Hiroshi Yamazaki
Journal:  Drug Metab Pharmacokinet       Date:  2009       Impact factor: 3.614

4.  Differential Fmo3 gene expression in various liver injury models involving hepatic oxidative stress in mice.

Authors:  Swetha Rudraiah; Jamie E Moscovitz; Ajay C Donepudi; Sarah N Campion; Angela L Slitt; Lauren M Aleksunes; José E Manautou
Journal:  Toxicology       Date:  2014-09-02       Impact factor: 4.221

5.  Oxidative stress-responsive transcription factor NRF2 is not indispensable for the human hepatic Flavin-containing monooxygenase-3 (FMO3) gene expression in HepG2 cells.

Authors:  Swetha Rudraiah; Xinsheng Gu; Ronald N Hines; José E Manautou
Journal:  Toxicol In Vitro       Date:  2015-11-23       Impact factor: 3.500

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.